SCHEMBL4746070

SCHEMBL4746070

c1cnc2c(c1)-c1cccc3c1c-2cc1c2ccccc2c(-c2nccc4ccccc24)cc31

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 2/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
HIF1A Q16665 1/20 0.41
MAOA P21397 1/20 0.39
BCHE P06276 1/20 0.38
MAPT P10636 4/20 0.38
KDM4E B2RXH2 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KMT2A Q03164 3/20 0.38
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
HTR7 P34969 1/20 0.38
HTR6 P50406 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13320351 0.90 L3MBTL1 (0.53) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4745841 0.89 ALDH1A1 (0.44) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4746464 0.89 ALDH1A1 (0.47) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4745930 0.87 ALDH1A1 (0.46) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4746267 0.87 ALDH1A1 (0.42) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4745832 0.86 ALDH1A1 (0.56) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4746392 0.85 ALDH1A1 (0.41) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4746199 0.84 TNF (0.47) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL16945547 0.84 ALDH1A1 (0.46) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL4746407 0.84 PTPRC (0.40) TOP2AL3MBTL1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 TOP2A 1041/4885L3MBTL1 1513/4885ALDH1A1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.